Projektdarstellungen auf der Webseite

Jedes von der Gebert Rüf Stiftung geförderte Projekt wird mit einer Webdarstellung zugänglich gemacht, die über die Kerndaten des Projektes informiert. Mit dieser öffentlichen Darstellung publiziert die Stiftung die erzielten Förderresultate und leistet einen Beitrag zur Kommunikation von Wissenschaft in die Gesellschaft.


Hemetron – Better rapid tests for better health


The project management is responsible for the content of the information provided.


  • Projekt-Nr: GRS-009/22 
  • Förderbeitrag: CHF 150'000 
  • Bewilligung: 05.05.2022 
  • Dauer: 01.2023 - 06.2024 
  • Handlungsfeld:  InnoBooster, seit 2018



Chronic inflammation is one of the largest unsolved healthcare issues of our society. Lifestyle adjustments such as optimized diets or increased physical activity are effective to fight chronic inflammations. However, every individual requires a different set of personalized adjustments. Unfortunately, there is currently no way to tailor the optimal anti-inflammatory measures to the personal needs of chronically inflamed individuals.
Hemetron develops a uniquely accurate and quantitative blood test for inflammation self-monitoring. Our solution empowers users to determine how to effectively decrease their inflammation.


During our GRS InnoBooster project, we convert our hand-held prototype into a mass producible beta product. This product will then be validated to ensure optimal performance. These steps allow us to move forward with user-testing to optimize the device for the needs of the customers and accelerate our market entry.


Am Projekt beteiligte Personen

E-mail for all requests webinfo@hemetron.notexisting@nodomain.comcom
Alexander Tanno, Postdoc at ETH Zürich and co-founder Hemetron AG
Yves Blickenstorfer, PhD at ETH Zürich and co-founder Hemetron AG
Vlastimil Jirasko, Postdoc at ETH Zürich and co-founder Hemetron AG

Letzte Aktualisierung dieser Projektdarstellung  30.05.2023